18,19-Dinorpregna-4,15-dien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17a)-

CAS : 60282-87-3

Ref. IN-DA00IAOE

Informations sur le produit

• Nom: 18,19-Dinorpregna-4,15-dien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17a)-
• Synonymes: [u'13-ethyl-17-hydroxy-18,19-dinor-17 alpha-pregna-4,15-dien-20-yn-3-one', u'17-alpha-ethinyl-13-ethyl-17 beta-hydroxy-4,15-gonadien-3-one', u'Gestoden', u'Gestodene', u'Gestodene, ((17alpha)-(+-))-isomer', u'SH B 3331', u'GESTODENE', u'60282-87-3', u'Gestoden', u'Gestodenum [INN-Latin]', u'Gestodeno [INN-Spanish]', u'Gestodeno', u'Gestodenum', u'SH B 331', u'Gestodene [USAN:INN:BAN]', u'UNII-1664P6E6MI', u'CCRIS 9189', u'HSDB 3594', u'EINECS 262-145-8', u'BRN 4237181', u'1664P6E6MI', u'Gestinol', u'17-alpha-Ethinyl-13-ethyl-17-beta-hydroxy-4,15-gonadien-3-one', u'13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregna-4,15-dien-20-yn-3-one', u'18,19-Dinorpregna-4,15-dien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17-alpha)-', u'DSSTox_CID_26478', u'DSSTox_RID_81649', u'DSSTox_GSID_46478', u'(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14-decahydrocyclopenta[a]phenanthren-3-one', u'13beta-Ethyl-17beta-hydroxy-18,19-dinorpregna-4,15-dien-20-yn-3-one', u'Pregna-4,15-dien-20-yn-3-one, 13-ethyl-17-hydroxy-18,19-dinor-, (17alpha)-', u'CAS-60282-87-3', u'NCGC00164611-01', u'SH B 3331', u'AC1MHWNV', u'Gestodene (USAN/INN)', u'SCHEMBL37271', u'CHEMBL1213583', u'DTXSID6046478', u'Gestodene, >=98% (HPLC)', u'SHB 331', u'SHB-331', u'SHT-546', u'CHEBI:135323', u'SIGSPDASOTUPFS-XUDSTZEESA-N', u'WL 70', u'17-alpha-ethinyl-13-ethyl-17 beta-hydroxy-4,15-gonadien-3-one', u'BCP22665', u'HY-B0110', u'Tox21_112232', u'MFCD00867858', u's1376', u'SH-546', u'13-ethyl-17-hydroxy-18,19-dinor-17 alpha-pregna-4,15-dien-20-yn-3-one', u'AKOS024462671', u'Tox21_112232_1', u'ZINC238809420', u'CS-1862', u'DB06730', u'NCGC00263565-01', u'AC-20038', u'AJ-45699', u'AK161682', u'AS-13029', u'CC-28967', u'LS-62068', u'SC-27288', u'AB2000072', u'FT-0082507', u'G0404', u'ST24047328', u'D04316', u'AB01274782-01', u'AB01274782_02', u'282G873', u'A832668', u'C-19235', u'Q-101426', u'BRD-K97197005-001-03-2', u'Gestodene, European Pharmacopoeia (EP) Reference Standard', u'17alpha -Ethynyl-17beta-hydroxy-18-methyl-4,15-estradien-3-one', u'17alpha-ethynyl-17beta-hydroxy-18-methyl-4,15-estradien-3-one', u'17alpha-ethynyl-17beta-hydroxy-18-methyl-estra-4,15-dien-3-one', u'(1S,2R,10R,11S,14R,15S)-15-ethyl-14-ethynyl-14-hydroxytetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-6,12-dien-5-one', u'(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one', u'(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-oxidanyl-1,2,6,7,8,9,10,11,12,14-decahydrocyclopenta[a]phenanthren-3-one', u'null', u'ethinylestradiol, gestodene', u'Gestodene [USAN:BAN:INN]', u'C21H26O2', u'17-(2-Propenyl)estr-4-en-17-ol', u'Gestodene, 99% - 100mg 100mg', u'ACN-029234', u'C21-H26-O2', u'CID3033968', u'CS-O-30926', u'Gestodene, ((17alpha)-(+-))-isomer', u'H056', u'B1517', u'C033273', u'18,19-Dinorpregna-4,15-dien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17.alpha.)-'], (17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one (non-preferred name), (17α)-13-Ethyl-17-hydroxy-18,19-dinorpregna-4,15-dien-20-yn-3-one, (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one (non-preferred name), 13-Ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one (non-preferred name), 18,19-Dinorpregna-4,15-dien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17α)-, Gestinol, Shb 331, Wl 70
• Marque: Indagoo

Propriétés chimiques

• Masse moléculaire: 310.4299
• Formule: C₂₁H₂₆O₂
• Degré de pureté: 98%
• Couleur/Forme: Solid
• InChI: InChI=1S/C21H26O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,10,12-13,16-19,23H,3,5-9,11H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1
• Code InChI: SIGSPDASOTUPFS-XUDSTZEESA-N